The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Abstract
Estimates of the worldwide incidence and mortality from 27 cancers in 2008 have been prepared for 182 countries as part of the GLOBOCAN series published by the International Agency for Research on Cancer. In this article, we present the results for 20 world regions, summarizing the global patterns for the eight most common cancers. Overall, an estimated 12.7 million new cancer cases and 7.6 million cancer deaths occur in 2008, with 56% of new cancer cases and 63% of the cancer deaths occurring in the less developed regions of the world. The most commonly diagnosed cancers worldwide are lung (1.61 million, 12.7% of the total), breast (1.38 million, 10.9%) and colorectal cancers (1.23 million, 9.7%). The most common causes of cancer death are lung cancer (1.38 million, 18.2% of the total), stomach cancer (738,000 deaths, 9.7%) and liver cancer (696,000 deaths, 9.2%). Cancer is neither rare anywhere in the world, nor mainly confined to high‐resource countries. Striking differences in the patterns of cancer from region to region are observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Research works printed but not linked: 35
- 10.1038/nrc1948 · DOI
- World Health Organization, 2002, National cancer control programmes. Policies and managerial guidelines
- Parkin DM, 1984, Estimated of the worldwide frequency of twelve major cancers, Bull WHO, 62, 163
- 10.1002/ijc.2910410205 · DOI · Paper page
- 10.1002/ijc.2910540413 · DOI · Paper page
- 10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P · DOI
- 10.1002/ijc.2910550604 · DOI · Paper page
- 10.1002/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M · DOI
- Ferlay J, 2001, GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5 [CD‐ROM]. Version 1.1
- Ferlay J, 2004, GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide IARC CancerBase No. 5 [Internet]. Version 2.0
- United Nations, Population division, World population prospects, the 2008 revision [Internet]
- Curado MP, 2007, IARC Scientific Publications No. 160
- Parkin DM, 2005, IARC CancerBase No. 7 [Internet]
- World Health Organisation (WHO) Databank, WHO statistical information system [Internet]
- World Health Organization, 2010, World health statistics 2010 [Internet]
- World Health Organization, 2008, The global burden of disease: 2004 update
- 10.1002/1097-0258(20000715)19:13<1741::AID-SIM496>3.0.CO;2-O · DOI
- 10.1002/sim.1481 · DOI · Paper page
- Cancer Registry of Norway. NORDPRED, A software for predicting trends in cancer incidence. [Internet]
- 10.1016/j.ejca.2009.12.014 · DOI · Paper page
- 10.1016/j.ejca.2004.09.007 · DOI
- Ministry of Health of China, 2008, Report of the 3rd National Retrospective Sample Survey of Mortality
- Engholm G, 2009, NORDCAN: cancer incidence, mortality, prevalence and prediction in the Nordic countries [Internet]; Version 3.5
- 10.1016/S1470-2045(09)70335-3 · DOI
- Quaglia A, 2005, Socio‐economic factors and health care system characteristics related to cancer survival in the elderly. A population‐based analysis in 16 European countries (ELDCARE project), Crit Rev Oncol Hematol, 54117
- GGDC, Home Maddison. [Internet]
- 10.1002/ijc.20471 · DOI
- 10.1038/sj.bjc.6602540 · DOI
- Segi M, 1960, Cancer mortality for selected sites in 24 countries (1950–57)
- 10.1186/1471-2407-2-37 · DOI
- 10.1093/jnci/djj187 · DOI
- Somdyala NI, Cancer incidence in a rural population of South Africa, 1998–2002, Int J Cancer
- 10.1016/j.canep.2009.09.008 · DOI
- Indian Council of Medical Research, 2006, National Cancer Registry Programme, Consolidated reports of population based cancer registries, 2001–2004, NCRP
- Bah E, 2002, IARC Scientific Publications No. 155
Cited by
Items 201–248 of 248
Baloch, Z., Li, Y., Yuan, T., Feng, Y., Liu, Y., Tai, W., Liu, L., Wang, B., Zhang, A.-M., Wu, X., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1562-7 · Cited by 42
Laker-Oketta, M. O., Wenger, M., Semeere, A., Castelnuovo, B., Kambugu, A., Lukande, R., Asirwa, F. C., Busakhala, N., Buziba, N., Diero, L., et al. (2015) · Oncology · doi:10.1159/000375165 · Cited by 41
Li, L., Feng, R., Xu, Q., Zhang, F., Liu, T., Cao, J., & Fei, S. (2017) · Oncotarget · doi:10.18632/oncotarget.20894 · Cited by 41
Lung cancer incidence trends in Uruguay 1990–2014: An age-period-cohort analysis
Alonso, R., Piñeros, M., Laversanne, M., Musetti, C., Garau, M., Barrios, E., & Bray, F. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.04.012 · Cited by 40
Self-citationVitamin D status and risk for malignant cutaneous melanoma: recent advances
Ombra, M. N., Paliogiannis, P., Doneddu, V., Sini, M. C., Colombino, M., Rozzo, C., Stanganelli, I., Tanda, F., Cossu, A., & Palmieri, G. (2017) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000334 · Cited by 39
Soto, D. R., Barton, C., Munger, K., & McLaughlin-Drubin, M. E. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006661 · Cited by 39
Liu, J., Sun, Y., Zhang, H., Ji, D., Wu, F., Tian, H., Liu, K., Zhang, Y., Wu, B., & Zhang, G. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.09.007 · Cited by 38
Lin, K.-Y., Frawley, H. C., Denehy, L., Feil, D., & Granger, C. L. (2016) · Physiotherapy · doi:10.1016/j.physio.2016.02.006 · Cited by 38
YANG, G., JIANG, O., LING, D., JIANG, X., YUAN, P., ZENG, G., ZHU, J., TIAN, J., WENG, Y., & WU, D. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3890 · Cited by 38
Screening for Cancer: Considerations for Low- and Middle-Income Countries
Sullivan, T., Sullivan, R., & Ginsburg, O. M. (2015) · Disease Control Priorities, Third Edition (Volume 3): Cancer · doi:10.1596/978-1-4648-0349-9_ch12 · Cited by 38
Acceptability of Self-Sampling HPV Testing Among Thai Women for Cervical Cancer Screening
Oranratanaphan, S., Termrungruanglert, W., & Khemapech, N. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.17.7437 · Cited by 37
‘Mind your Moles’ study: protocol of a prospective cohort study of melanocytic naevi
Koh, U., Janda, M., Aitken, J. F., Duffy, D. L., Menzies, S., Sturm, R. A., Schaider, H., Betz-Stablein, B., Prow, T., Soyer, H. P., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-025857 · Cited by 36
Salas, L. A., Villanueva, C. M., Tajuddin, S. M., Amaral, A. F. S., Fernandez, A. F., Moore, L. E., Carrato, A., Tardón, A., Serra, C., García-Closas, R., et al. (2014) · Epigenetics · doi:10.4161/15592294.2014.983377 · Cited by 34
Prevalence of human papillomavirus types in cervical lesions from women in rural Western India
Deodhar, K., Gheit, T., Vaccarella, S., Romao, C. C., Tenet, V., Nene, B. M., Jayant, K., Kelkar, R., Malvi, S. G., Sylla, B. S., et al. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23310 · Cited by 34
Acceptability of HPV vaccine implementation among parents in India
Paul, P., Tanner, A. E., Gravitt, P. E., Vijayaraghavan, K., Shah, K. V., Zimet, G. D., & Study Group, C. (2014) · Health Care for Women International · doi:10.1080/07399332.2012.740115 · Cited by 34
Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment
Lehmann, M., Hoffmann, M. J., Koch, A., Ulrich, S. M., Schulz, W. A., & Niegisch, G. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0059-8 · Cited by 34
Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas
Mudianto, T., Campbell, K. M., Webb, J., Zolkind, P., Skidmore, Z. L., Riley, R., Barnell, E. K., Ozgenc, I., Giri, T., Dunn, G. P., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-4179 · Cited by 33
Recent advances in polymeric core–shell nanocarriers for targeted delivery of chemotherapeutic drugs
Yang, X., & Xie, Y. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121094 · Cited by 33
Prognostic Significance of MicroRNAs in Glioma: A Systematic Review and Meta-Analysis
Zhang, Y., Chen, J., Xue, Q., Wang, J., Zhao, L., Han, K., Zhang, D., & Hou, L. (2019) · BioMed Research International · doi:10.1155/2019/4015969 · Cited by 32
Li, W., Sun, J., Zhang, X., Jia, L., Qiao, M., Zhao, X., Hu, H., Chen, D., & Wang, Y. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020111 · Cited by 31
Patterns and determinants of mammography screening in Lebanese women
Elias, N., Bou-Orm, I. R., & Adib, S. M. (2017) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2016.12.015 · Cited by 31
Li, Y., Yang, Y., Zhang, R., Yao, K., & Liu, Z. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142913 · Cited by 30
Lin, M., Chen, Y., Lee, M., Weng, K., Chang, H., Yu, S., Dong, B., Kuo, F., Hung, L., Liu, L., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8557 · Cited by 30
Developing a complex intervention to reduce time to presentation with symptoms of lung cancer
Smith, S. M., Murchie, P., Devereux, G., Johnston, M., Lee, A. J., Macleod, U., Nicolson, M. C., Powell, R., Ritchie, L. D., Wyke, S., et al. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x654579 · Cited by 29
Farag, M. A., Reda, A., Nabil, M., Elimam, D. M., & Zayed, A. (2023) · Food & Function · doi:10.1039/d3fo01949g · Cited by 28
Srivastava, K., Pickard, A., McDade, S., & McCance, D. J. (2017) · Oncotarget · doi:10.18632/oncotarget.3892 · Cited by 28
Lee, J. T., Huang, Z., Basu, S., & Millett, C. (2015) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2014-204355 · Cited by 27
Yoshino, T., Obermannová, R., Bodoky, G., Garcia-Carbonero, R., Ciuleanu, T., Portnoy, D. C., Kim, T. W., Hsu, Y., Ferry, D., Nasroulah, F., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.03.007 · Cited by 27
Phenylpropanoids, eugenol scaffold, and its derivatives as anticancer
Fadilah, F., Yanuar, A., Arsianti, A., & Andrajati, R. (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i3.16071 · Cited by 28
Sestak, I., Smith, S. G., Howell, A., Forbes, J. F., & Cuzick, J. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx713 · Cited by 27
Naing, C., Aung, K., Lai, P. K., & Mak, J. W. (2017) · BMC Cancer · doi:10.1186/s12885-016-2997-3 · Cited by 27
Zhang, Y., Xu, H., Wang, T., He, J., Qiao, Y., Wei, J., & Dong, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0144410 · Cited by 19
Jagielski, C. H., Tucker, D. C., Dalton, S. O., Mrug, S., Würtzen, H., & Johansen, C. (2020) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2019.1626524 · Cited by 20
Kap, E. J., Seibold, P., Richter, S., Scherer, D., Habermann, N., Balavarca, Y., Jansen, L., Becker, N., Pfütze, K., Popanda, O., et al. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.8 · Cited by 20
Ohlsson-Nevo, E., Karlsson, J., & Nilsson, U. (2016) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2015.10.002 · Cited by 20
Potential role of regulatory B cells in immunological diseases
Valizadeh, A., Sanaei, R., Rezaei, N., Azizi, G., Fekrvand, S., Aghamohammadi, A., & Yazdani, R. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.08.004 · Cited by 16
Xie, M., Zhou, L., Li, T., Lin, Y., Zhang, R., Zheng, X., Zeng, C., Zheng, L., Zhong, L., Huang, X., et al. (2024) · Advanced Science · doi:10.1002/advs.202310146 · Cited by 18
Huchko, M. J., Kahn, J. G., Smith, J. S., Hiatt, R. A., Cohen, C. R., & Bukusi, E. (2017) · BMC Cancer · doi:10.1186/s12885-017-3818-z · Cited by 18
Kotha, R., Fernandes, G., Nikam, A. N., Kulkarni, S., Pandey, A., Pandey, S., & Mutalik, S. (2020) · Materials Science and Technology · doi:10.1080/02670836.2020.1832323 · Cited by 17
Padmyastuti, A., Sarmiento, M. G., Dib, M., Ehrhardt, J., Schoon, J., Somova, M., Burchardt, M., Roennau, C., & Pinto, P. C. (2023) · Scientific Reports · doi:10.1038/s41598-023-38834-y · Cited by 17
Huang, P.-H., Hu, C.-C., Chien, C.-H., Chen, L.-W., Chien, R.-N., Lin, Y.-S., Chao, M., Lin, C.-L., & Yeh, C.-T. (2019) · Journal of Cancer · doi:10.7150/jca.33221 · Cited by 15
Grégoire, C., Faymonville, M.-E., Vanhaudenhuyse, A., Charland-Verville, V., Jerusalem, G., & Bragard, I. (2018) · BMC Cancer · doi:10.1186/s12885-018-5046-6 · Cited by 14
Wang, D., Li, W., Yin, L., Du, Y., Zhang, S., & Suo, J. (2020) · Oncology Letters · doi:10.3892/ol.2020.11350 · Cited by 12
WNT/β-catenin pathway activation in hepatocellular carcinoma: a clinical perspective
Chua, M.-S., Ma, L., Wei, W., & So, S. (2014) · Gastrointestinal Cancer: Targets and Therapy · doi:10.2147/gictt.s44256 · Cited by 12
A high-fat diet increases the incidence of mammary cancer inc-Ha-ras proto-oncogene transgenic rats
Magaki, M., Ishii, H., Yamasaki, A., Kitai, Y., Kametani, S., Nakai, R., Dabid, A., Tsuda, H., & Ohnishi, T. (2017) · Journal of Toxicologic Pathology · doi:10.1293/tox.2016-0052 · Cited by 10
Rlip Depletion Suppresses Growth of Breast Cancer
Bose, C., Yadav, S., Singhal, S. S., Singhal, J., Hindle, A., Lee, J., Cheedella, N. K. S., Rehman, S., Layeequr Rahman, R., Jones, C., et al. (2020) · Cancers · doi:10.3390/cancers12061446 · Cited by 10
He, Y., Chen, F., Cai, Y., & Chen, S. (2016) · Cell Biology International · doi:10.1002/cbin.10593 · Cited by 8
RetractedSmoking-attributable burden of lung cancer in the Philippines
Bilano, V. L. F., Borja, M. P., Cruz, E. L., Tan, A. G., Mortera, L. L., & Reganit, P. F. M. (2015) · Tobacco Control · doi:10.1136/tobaccocontrol-2013-051082 · Cited by 7
Metadata
- Authors
- Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2010-06-17
- Volume
- 127
- Issue
- 12
- Pages
- 2893-2917
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1981989535
- Cited by
- 21,293
- References
- 1
- FWCI
- 753.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
